APA

Walker L. J., Aldhous M. C., Drummond H. E., Smith B. R. K., Nimmo E. R., Arnott I. D. R. & Satsangi J. (20040420). Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. : Clinical and experimental immunology.

Chicago

Walker L J, Aldhous M C, Drummond H E, Smith B R K, Nimmo E R, Arnott I D R and Satsangi J. 20040420. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. : Clinical and experimental immunology.

Harvard

Walker L. J., Aldhous M. C., Drummond H. E., Smith B. R. K., Nimmo E. R., Arnott I. D. R. and Satsangi J. (20040420). Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. : Clinical and experimental immunology.

MLA

Walker L J, Aldhous M C, Drummond H E, Smith B R K, Nimmo E R, Arnott I D R and Satsangi J. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. : Clinical and experimental immunology. 20040420.